Provided by Tiger Trade Technology Pte. Ltd.

Artelo Biosciences, Inc.

6.36
+0.39576.63%
Post-market: 5.91-0.4499-7.07%17:19 EDT
Volume:586.79K
Turnover:3.89M
Market Cap:3.48M
PE:-0.06
High:6.79
Open:5.95
Low:5.34
Close:5.96
52wk High:249.75
52wk Low:4.68
Shares:547.78K
Float Shares:547.42K
Volume Ratio:0.82
T/O Rate:107.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-102.4149
EPS(LYR):-337.9329
ROE:-705.71%
ROA:-127.92%
PB:0.70
PE(LYR):-0.02

Loading ...

U.S. Markets Open Mixed as Focus Turns to SpaceX Nasdaq Debut

Deep News
·
Jun 12

Artelo Biosciences reports favorable human metabolite profile for ART26.12 in completed SAD trial

Reuters
·
Jun 10

Artelo Biosciences Launches Flexible At-The-Market Offering

TIPRANKS
·
May 28

Top Premarket Decliners

MT Newswires Live
·
May 27

Artelo Biosciences announces annual shareholder meeting

Reuters
·
May 27

Artelo Biosciences Inc - to Offer up to $6.53 Mln in Common Stock via H.c. Wainwright - SEC Filing

THOMSON REUTERS
·
May 27

Top Premarket Gainers

MT Newswires Live
·
May 26

Wall Street Expands Crypto Asset Integration as SEC Approves Nasdaq's Bitcoin Options Product

Stock News
·
May 23

Global Financial Headlines: Pershing Square Takes Position in Microsoft, Mehlan Steps Down from Fed, SpaceX Picks Nasdaq for IPO

Deep News
·
May 16

Artelo Biosciences Ends ATM Offering, Shifts Financing Strategy

TIPRANKS
·
May 16

Artelo Biosciences Inc - to Terminate at-the-Market Offering Agreement Effective May 18, 2026 - SEC Filing

THOMSON REUTERS
·
May 16

Dollar's Resurgence Weighs on Gold as Tech Stocks Face Potential Pressure

Deep News
·
May 15

Artelo Biosciences Q1 EPS $(4.00) Misses $(1.57) Estimate

Benzinga Earnings
·
May 15

Artelo Biosciences Q1 FY26 net loss widens 24.7% to USD 2.96 million

Reuters
·
May 15

Artelo Biosciences Provides Business Update Outlining Upcoming Milestones and Reports 2026 First Quarter Financial Results

THOMSON REUTERS
·
May 15

BRIEF-Artelo Biosciences May Offer Securities Up To $75 Million - SEC Filing

Reuters
·
May 05

Artelo Biosciences files $75M mixed securities shelf

TIPRANKS
·
May 05

Artelo Biosciences Inc - May Offer Securities up to $75 Mln - SEC Filing

THOMSON REUTERS
·
May 05

Artelo Biosciences partners with ScienceMachine to accelerate FABP5 inhibitor development

Reuters
·
Apr 28

Artelo Biosciences Inc - Announces Strategic Partnership With Sciencemachine for Fabp5 Inhibitor Development

THOMSON REUTERS
·
Apr 28